Opinion
JAMA Commentary Says New Dietary Guidelines for Americans Give Undue Prominence to Meat & Dairy
A new commentary published in the Journal of the American Medical Association (JAMA) has expressed concern that the updated Dietary Guidelines for Americans ...
The DEPEND study demonstrates that checkpoint inhibitor nivolumab (Opdivo®) works best with high levels of PD-L1 biomarker, but does not work well with low levels of PD-L1 Multikine* is uniquely ...
BUFFALO, N.Y. – People with opioid use disorder who have hepatitis C virus (HCV) were twice as likely to be successfully treated and cured from HCV if they received facilitated telemedicine treatment ...
40% of U.S. adults are now considered obese, leading to a dramatic surge in the utilization of the popular but pricey weight-loss drugs PITTSBURGH, Sept. 17, 2025 /PRNewswire/ -- For obese patients, ...
PARAMUS, N.J., April 2, 2025 /PRNewswire/ -- Octapharma USA announced the Journal of the American Medical Association (JAMA) has published results from a Phase III clinical trial, which observed ...
Prestigious recognition underscores the impact of large-scale genomic screening in identifying serious childhood genetic conditions in conjunction with traditional newborn screening GAITHERSBURG, Md.- ...
BERLIN--(BUSINESS WIRE)--Data published in The Journal of the American Medical Association (JAMA) from the pivotal Phase III studies OASIS 1 and 2, evaluating the efficacy and safety of the ...
CAMBRIDGE, Mass., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – today announced that The Journal of the American Medical Association (JAMA) Neurology has published final results from ...
RADNOR, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results